DANIEL MYERS
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
DANIEL BOLLAG, STEVEN CAGNETTA, JASWINDER CHADHA, ALAN CRAIN, ALAN CRANE, JAMES GARVEY, MICHAEL GOLDSTEIN, BERNARD HAFFEY, KEVIN HANLEY, JEFFREY S. HEIER, FARHAD KHOSRAVI, BRIAN LEVY, RICHARD LINDSTROM, RICHARD L. LINDSTROM, ANTONY MATTESSICH, DONALD NOTMAN, W. JAMES O-SHEA, BRUCE A. PEACOCK, AMARPREET SAWHNEY, CHARLES WARDEN, SAMUEL WU
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
PHILIP ASHMAN, GLEN BRADLEY, MARK BROOKS, SUSAN CABALLA, RICHARD EISWIRTH, RICHARD S. EISWIRTH, RICHARD S. EISWIRTH, JR., KENNETH GREEN, BRIAN HALAK, BRIAN K. HALAK, DAVID HOLLAND, ANDERS HOVE, J. PHILIP JONES, MICHAEL KASETA, GARHENG KONG, JAMES R. LARGENT, ADAM MORGAN, C. DANIEL MYERS, CHARLES DANIEL MYERS, ERIN PARSONS, PETER J. PIZZO, PETER J. PIZZO III, CALVIN ROBERTS, CALVIN W. ROBERTS, ROGER SAWHENY, RUSSELL SKIBSTED, JOHN SNISARENKO, MARY T. SZELA, PHIL TRACY, PHILIP TRACY, BRYCE YOUNGREN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2023-03-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2023-03-24

